Rise and shine. Another day is on the way. To top it off, the sun is shining here on the Pharmalot corporate campus, where we are hustling the short people off to the schoolhouse. Wish us luck. Meanwhile, there is much to do. So why not start with the mandatory cup of stimulation and the news of the world. Have a great day, everyone...
Glaxo Wins FDA OK For Prostate Combo Drug (Reuters)
Cheap Generic May Save Lives After Bleeding From Accidents (Bloomberg News)
ACRO Wants More US & European Trial Investigators (Outsourcing Pharma)
Genmab CEO Steps Down Under Fire (Reuters)
Waiting For The Human Genome To Yield Drugs (The New York Times)
Georgia Creates Bioscience Center (Atlanta Journal-Constitution)
Cleveland Clinics Inks Research Deal With Lipitor Creator (Crain's Cleveland Business)
1 Comment
I'm surprised at the drop in the number of US investigators. The Bible of medical practice, otherwise known as Medical Economics periodically runs articles on how doctors can pad their incomes by doing trial work on the side. The rule of thumb is that if you put in one our a day seeing trials patients you can jack your yearly income by about 20%. Given that doctors far outranked the other top 20 profession by income in one recent money magazine survey, maybe they don't need the money.